2009
DOI: 10.1074/jbc.m109.033431
|View full text |Cite
|
Sign up to set email alerts
|

Paraquat Toxicity Induced by Voltage-dependent Anion Channel 1 Acts as an NADH-dependent Oxidoreductase

Abstract: Paraquat (PQ), a herbicide used worldwide, causes fatal injury to organs upon high dose ingestion. Treatments for PQ poisoning are unreliable, and numerous deaths have been attributed inappropriate usage of the agent. It is generally speculated that a microsomal drug-metabolizing enzyme system is responsible for PQ toxicity. However Paraquat (PQ 2 ; methyl viologen, 1,1Ј-dimethyl-4,4Ј-bipyridinium dichloride) is an effective herbicide used in more than 120 countries (1). Although it is classified as a low haza… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
13
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 33 publications
3
13
0
Order By: Relevance
“…Our data suggest that PQ‐induced toxicity is mediated via QR2 activity. Several other oxidoreductases have also been implicated in PQ bioactivation, such as NADPH oxidases of the Nox family (Miller et al ., 2007; Cristovao et al ., 2009), a DPI‐sensitive thioredoxin reductase (Gray et al ., 2007), as well as a mitochondrial NADH‐dependent reductase (Shimada et al ., 2009). However, in spite of a wide specificity of QR2 in terms of substrates and co‐substrates, it is unlikely that QR2 directly catalyses the conversion of the PQ di‐cation into a PQ radical, thus using PQ as a substrate in a mechanism analogous to the diaphorases listed above.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our data suggest that PQ‐induced toxicity is mediated via QR2 activity. Several other oxidoreductases have also been implicated in PQ bioactivation, such as NADPH oxidases of the Nox family (Miller et al ., 2007; Cristovao et al ., 2009), a DPI‐sensitive thioredoxin reductase (Gray et al ., 2007), as well as a mitochondrial NADH‐dependent reductase (Shimada et al ., 2009). However, in spite of a wide specificity of QR2 in terms of substrates and co‐substrates, it is unlikely that QR2 directly catalyses the conversion of the PQ di‐cation into a PQ radical, thus using PQ as a substrate in a mechanism analogous to the diaphorases listed above.…”
Section: Discussionmentioning
confidence: 99%
“…Several NAD(P)H‐dependent diaphorases have been identified as PQ‐reducing enzymes. These include, cytoplasmic NADPH oxidases of the Nox family (Miller et al ., 2007; Cristovao et al ., 2009), a diphenylene iodonium (DPI)‐sensitive thioredoxin reductase, highly expressed in alveolar epithelium (Gray et al ., 2007), mitochondrial oxidoreductases present in the electron transport Complex I (Cocheme and Murphy, 2008) and Complex III (Castello et al ., 2007; Drechsel and Patel, 2009) or a mitochondrial NADH‐dependent reductase VDAC1 (Shimada et al ., 2009). Finally, it cannot be excluded that oxidoreductases that preferentially use an alternative electron donor to NAD(P)H, are also involved in PQ‐induced cytotoxicity.…”
Section: Introductionmentioning
confidence: 99%
“…Although it seems unlikely that VDAC1 would function as a reductase in mitochondria, there have been two recent reports claiming that mitochondrial VDAC1 is functional as an NADH-dependent reductase. A first report suggested that mitochondrial VDAC1's reductase activity is responsible for the reductive activation of quinone anticancer drugs like 2-methyl-furanonaphthoquinone and 2-methyl-5-hydroxy-furanonaphthoquinone [47]; a second report claimed that it is VDAC1's NADH:paraquat reductase activity in the mitochondria that is responsible for paraquat toxicity [48]. As discussed above, NADH can regulate the gating of VDAC [36] and adenosine nucleotides can be transported by the molecule [49].…”
Section: Functional Features Of Vdac In the Plasma Membranementioning
confidence: 99%
“…109 Whether this phenotype reflects the observed defects in pink1 and parkin mutants, and moreover, whether these mutants genetically interact is unclear; however, certain pieces of information support the concept of VDAC1 playing a role in PD pathogenesis, such as VDAC1-dependent ROS generation and release in the context of paraquat and dopamine toxicity. 110,111 In addition, a role of VDAC1 in mitophagy has already been suggested. Furthermore, VDAC1 has been proposed to contribute also to other neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) 112 and Alzheimer disease (AD) (reviewed in ref.…”
Section: O N O T D I S T R I B U T Ementioning
confidence: 99%